Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.321NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.321NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.379NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.379NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.379NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.78NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.78NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.78NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.231NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.231NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.231NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.49NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.49NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.67NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.67NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.190NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.190NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.190NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.120NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.120NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.120NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AM.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.249NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.249NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.249NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.505NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.505NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.505NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.74NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.1.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.1.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.406NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.406NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.406NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.115NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.115NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.115NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used